Volta Medical - Gilde Healthcare

Volta Medical


Marseille, France

Software for Electrophysiology
Since: 2020

French Healthtech company developing AI software solutions to assist in cardiac operations.

Founded by three cardiologists and a data scientist in 2016 in Marseille, Volta Medical is a HealthTech company developing artificial intelligence (AI) software solutions to assist cardiac electrophysiologists in the operating room. Volta’s overarching goal is to drastically improve cardiac arrythmia management by developing state-of-the-art, data-driven medical devices trained on large databases of procedural data with the highest standards of data protection. Its first product, VX1, assists cardiologists for the real-time identification of specific abnormal electrograms, known as dispersed electrograms.

In September 2020, Volta attained FDA approval for its VX1 system, a first for an AI based software in interventional electrophysiology. Gilde invested in Volta in 2020 to enable the company to establish its revolutionary FDA-cleared and CE marked VX1 AI software solution as a new standard of care, pursue further R&D activities and start to roll out commercial activities across the US and Europe.

More Volta Medical news

Volta Medical Announces Initiation of RESTART Clinical Trial for Treatment of Repeat Atrial Fibrillation

Gilde Healthcare company Volta medical secures €36M in Series B funding

Gilde Healthcare Company Volta Medical publishes clinical results on AI based solution for patients in atrial fibrillation

Gilde Healthcare portfolio Volta Medical treats first U.S. patients with persistent cardiac arrythmias

Gilde Healthcare leads $28 million financing in Volta Medical to revolutionize persistent AFib ablation